NEW YORK (GenomeWeb News) – Thermo Fisher Scientific recorded about $55.6 million in restructuring charges related to the termination of employees during 2013, the company said in its Form 10-K on Thursday.

The company took charges in its Analytical Technologies segment of $18.5 million; in its Specialty Diagnostics segment of $17.8 million; in its Laboratory and Products Services segment of $16.3 million; and in corporate of $3.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.